These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 15051014)
1. Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. Fahy BN; Schlieman MG; Virudachalam S; Bold RJ J Am Coll Surg; 2004 Apr; 198(4):591-9. PubMed ID: 15051014 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312 [TBL] [Abstract][Full Text] [Related]
3. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146 [TBL] [Abstract][Full Text] [Related]
4. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Arlt A; Gehrz A; Müerköster S; Vorndamm J; Kruse ML; Fölsch UR; Schäfer H Oncogene; 2003 May; 22(21):3243-51. PubMed ID: 12761494 [TBL] [Abstract][Full Text] [Related]
5. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway. Liu J; Huang Y; Liu Y; Chen Y Med Sci Monit; 2019 Aug; 25():6085-6096. PubMed ID: 31412018 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine. Yokoi K; Fidler IJ Clin Cancer Res; 2004 Apr; 10(7):2299-306. PubMed ID: 15073105 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB. El-Rayes BF; Ali S; Ali IF; Philip PA; Abbruzzese J; Sarkar FH Cancer Res; 2006 Nov; 66(21):10553-9. PubMed ID: 17079479 [TBL] [Abstract][Full Text] [Related]
8. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer. Mortenson MM; Galante JG; Gilad O; Schlieman MG; Virudachalam S; Kung HJ; Bold RJ J Cell Biochem; 2007 Dec; 102(5):1171-9. PubMed ID: 17960583 [TBL] [Abstract][Full Text] [Related]
10. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Banerjee S; Zhang Y; Ali S; Bhuiyan M; Wang Z; Chiao PJ; Philip PA; Abbruzzese J; Sarkar FH Cancer Res; 2005 Oct; 65(19):9064-72. PubMed ID: 16204081 [TBL] [Abstract][Full Text] [Related]
11. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways. Li J; Liang X; Yang X Oncol Rep; 2012 Aug; 28(2):501-10. PubMed ID: 22641480 [TBL] [Abstract][Full Text] [Related]
12. Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-kappaB signaling pathway with the anti-epidermal growth factor antibody IMC-C225. Sclabas GM; Fujioka S; Schmidt C; Fan Z; Evans DB; Chiao PJ J Gastrointest Surg; 2003 Jan; 7(1):37-43; discussion 43. PubMed ID: 12559183 [TBL] [Abstract][Full Text] [Related]
13. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation. Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032 [TBL] [Abstract][Full Text] [Related]
14. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine]. Liu A; Hu YS; Wang ZH; Tang LL; Ke PY; Lin SZ Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284 [TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy. Mamaghani S; Patel S; Hedley DW BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol. Zhou L; Qi L; Jiang L; Zhou P; Ma J; Xu X; Li P AAPS J; 2014 Mar; 16(2):246-57. PubMed ID: 24424498 [TBL] [Abstract][Full Text] [Related]
17. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo. Wang YW; Wang SJ; Zhou YN; Pan SH; Sun B J Cancer Res Clin Oncol; 2012 May; 138(5):785-97. PubMed ID: 22270965 [TBL] [Abstract][Full Text] [Related]
18. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells. Holcomb BK; Yip-Schneider MT; Waters JA; Beane JD; Crooks PA; Schmidt CM J Gastrointest Surg; 2012 Jul; 16(7):1333-40. PubMed ID: 22618517 [TBL] [Abstract][Full Text] [Related]
19. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling. Liu J; Ma J; Wu Z; Li W; Zhang D; Han L; Wang F; Reindl KM; Wu E; Ma Q BMC Cancer; 2014 Sep; 14():686. PubMed ID: 25240403 [TBL] [Abstract][Full Text] [Related]
20. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]